NCT07060586

Brief Summary

The purpose of this study is to evaluate the effect of sphenopalatine ganglion block (SPG block) on headache and veisalgia (hangover) the day after attending the metal festival Copenhell.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2025

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 11, 2025

Completed
Last Updated

July 11, 2025

Status Verified

July 1, 2025

Enrollment Period

3 days

First QC Date

June 23, 2025

Last Update Submit

July 10, 2025

Conditions

Keywords

HangoverSPGB

Outcome Measures

Primary Outcomes (1)

  • Headache Pain Intensity 10 minutes after SPGB

    Pain intensity (0-100 mm on a visual analog scale, VAS) of the headache in a standing position 10 minutes after administration of the block in the Ropivacaine-Lidocaine group and the Sham group. Pain intensity is measured as the worst pain experienced after the person has been standing for 30 seconds, or as the worst pain during the attempt to stand if the test must be aborted.

    10 minutes following block

Secondary Outcomes (4)

  • Pain score below 30mm (VAS)

    10 minutes following block

  • Difference in headache pain intensity in standing position

    10 minutes following block

  • Severity of veisalgia

    10 minutes following block

  • Difference in veisalgia severity

    10 minutes following block

Study Arms (2)

Block (Lidocaine + Ropivacaine)

EXPERIMENTAL
Procedure: Sphenopalatine Ganglion Block

Sham block (Saline)

SHAM COMPARATOR

Incomplete block with saline (no contact with ganglion)

Procedure: Sham Block

Interventions

A bilateral transnasal sphenopalatine ganglion block with cotton tips soaked in a mixture of 0.5 mL lidocaine 4% and 0.5 mL ropivacaine 0.5% plus injection through the cotton tips of an additional 1 mL of the mixture. The Danish Medicines Agency waived need for approval as this procedure is not considered a pharmaceutical intervention.

Block (Lidocaine + Ropivacaine)
Sham BlockPROCEDURE

A sham block with two bilaterally inserted cotton tips not reaching the posterior part of the nasopharyngeal making not contact with the ganglion. Cotton tips are soaked in 1 mL placebo (saline) and have a total of 1 mL saline injected through the cotton tips. The Danish Medicines Agency waived need for approval as this procedure is not considered a pharmaceutical intervention.

Sham block (Saline)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets screening criteria and is present on the day of intervention
  • Moderate to severe headache (defined as ≥ 3 on a 0-10 VAS) on the day of intervention

You may not qualify if:

  • Intake of alcohol or other intoxicating substances after waking up on the day of intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Copenhell 2025

Copenhagen, Denmark

Location

MeSH Terms

Conditions

Headache

Interventions

Sphenopalatine Ganglion Block

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Autonomic Nerve BlockNerve BlockAnesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaDenervationNeurosurgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Professor

Study Record Dates

First Submitted

June 23, 2025

First Posted

July 11, 2025

Study Start

June 18, 2025

Primary Completion

June 21, 2025

Study Completion

June 21, 2025

Last Updated

July 11, 2025

Record last verified: 2025-07

Locations